Viewing Study NCT01167166


Ignite Creation Date: 2025-12-24 @ 4:37 PM
Ignite Modification Date: 2026-01-01 @ 6:28 AM
Study NCT ID: NCT01167166
Status: COMPLETED
Last Update Posted: 2017-06-26
First Post: 2010-07-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL)
Sponsor:
Organization: